| Day 1 | Day 4 | Day 7 | At first follow-up (Day 15) | At second follow-up (after 3 weeks of treatment) |
---|---|---|---|---|---|
Hemoglobin (gm/dl) | 12.4 | 11.8 | 12.1 | 13.9 | 12.9 |
White cell count (/mm3) | 16,510 | 13,500 | 17,890 | 21,460 | 12,680 |
Differentials | N78L12E02M08 | N80L11M09 | N90L04E02M04 | N83L06E02M09 | N94L04E01M01 |
Platelets (/mm3) | 381,000 | 2,44,000 | 395,000 | 238,000 | 211,000 |
C-Reactive Protein (mg/L) | Â | 82.25 | 29.49 | 17.68 | 2.578 |
Random Blood Sugar (mg/dl) | 155 | Â | Â | Â | Â |
Serum creatinine (mg/dl) | 0.9 | 0.72 | 1.05 | 1.27 | 1.14 |
Serum urea (mg/dl) | 22 | 27 | 33.9 | 39 | 44.2 |
Serum Sodium (mmol/L) | 140 | 134 | 138 | 137 | 135 |
Serum Potassium (mmol/L) | 3.9 | 4.3 | 4.1 | 4.1 | 4.6 |
Serum total bilirubin (mg/dl) | 0.2 | 0.37 | Â | 0.2 | 0.25 |
Serum direct bilirubin (mg/dl) | 0.1 | 0.17 | Â | 0.12 | 0.12 |
Alanine transaminase (ALT) (IU/L) | 24 | 19.4 | 61 | 69.2 | 30.2 |
Aspartate transaminase (AST)(IU/L) | 14 | 12.3 | 68 | 23.3 | 17.1 |
Serum total protein (gm/dl) | 6.9 | 6.79 | Â | 6.56 | 6.19 |
Serum albumin (gm/dl) | 3.3 | 3.19 | Â | 3.57 | 3.99 |
Urine RE/ME Albumin 1 +  RBC: 3–5/HPF WBC: 4–6/HPF Epithelial cells: 2–3/HPF RBC morphology: 5% dysmorphic RBCs seen |  |  |  |  |  |
24-h urinary total protein (mg/24Â h) | Â | 329.64 | Â | Â | Â |